☰

Megan Agajanian - Publications

Affiliations: 
2013-2015 Biology California State University, Northridge, Los Angeles, CA, United States 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Hamalian S, Güth R, Runa F, Sanchez F, Vickers E, Agajanian M, Molnar J, Nguyen T, Gamez J, Humphries JD, Nayak A, Humphries MJ, Tchou J, Zervantonakis IK, Kelber JA. A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers. Oncogene. PMID 34239043 DOI: 10.1038/s41388-021-01906-2  0.765
2020 Tamir TY, Bowman BM, Agajanian MJ, Goldfarb D, Schrank TP, Stohrer T, Hale AE, Siesser PF, Weir SJ, Murphy RM, LaPak KM, Weissman BE, Moorman NJ, Major MB. Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor. Journal of Cell Science. PMID 32546533 DOI: 10.1242/Jcs.241356  0.302
2019 Güth R, Adamian Y, Geller C, Molnar J, Maddela J, Kutscher L, Bhakta K, Meade K, Kim SL, Agajanian M, Kelber JA. DHPS-dependent hypusination of eIF5A1/2 is necessary for TGFβ/fibronectin-induced breast cancer metastasis and associates with prognostically unfavorable genomic alterations in TP53. Biochemical and Biophysical Research Communications. PMID 31558321 DOI: 10.1016/J.Bbrc.2019.09.075  0.762
2018 Hamalian S, Güth R, Zervantonakis I, Duell E, Lin J, Shisgal P, Molnar J, Geller C, Agajanian M, Tchou J, Sorger PK, Brugge JS, Kelber JA. Abstract 2140: Mesenchymal stromal cells expressing a PEAK1/Cripto axis sustain pro-survival NF-κB signaling in adjacent tumor cells to promote disease progression and therapy resistance Cancer Research. 78: 2140-2140. DOI: 10.1158/1538-7445.Am2018-2140  0.633
2016 Gharibi A, Kim SL, Brambilla D, Adamian Y, Hoover M, Lin J, Agajanian M, Wolfenden L, Kelber JA. Abstract 4426: The PEAK1/ZEB1/ITGA1 pathway mediates survival, stemness and TGFbeta-induced EMT in pancreatic cancer Cancer Research. 76: 4426-4426. DOI: 10.1158/1538-7445.Am2016-4426  0.732
2015 Agajanian M, Runa F, Kelber JA. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer. Biochemical and Biophysical Research Communications. 465: 606-12. PMID 26297948 DOI: 10.1016/J.Bbrc.2015.08.071  0.853
2015 Agajanian M, Campeau A, Hoover M, Hou A, Brambilla D, Kim SL, Klemke RL, Kelber JA. PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer. Plos One. 10: e0135748. PMID 26267863 DOI: 10.1371/Journal.Pone.0135748  0.862
2015 Agajanian M, Runa F, Kelber JA. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer Biochemical and Biophysical Research Communications. DOI: 10.1016/j.bbrc.2015.08.071  0.779
Show low-probability matches.